EIF4A3-mediated circ_0042881 activates the RAS pathway via miR-217/SOS1 axis to facilitate breast cancer progression
Chenxi Ju(First Affiliated Hospital of Zhengzhou University), Jing He(First Affiliated Hospital of Zhengzhou University), Mingxia Zhou(First Affiliated Hospital of Zhengzhou University), Hongle Li(Shanghai Jiao Tong University), Yang Luo(Kunming University), Chang Wang(First Affiliated Hospital of Zhengzhou University), Fucheng He(First Affiliated Hospital of Zhengzhou University), Jieqiong Yao(Second Affiliated Hospital of Zhengzhou University), Dan Du(Sichuan University)
Cited by 34
Related Papers
MEK inhibitors for the treatment of non-small cell lung cancer
|Journal of Hematology & Oncology|2021|300
Determination of Environmental Exposure to Microcystin and Aflatoxin as a Risk for Renal Function Based on 5493 Rural People in Southwest China
|Environmental Science & Technology|2016|92
Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma
|Journal of Experimental & Clinical Cancer Research|2016|86
LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis
|Biomedicine & Pharmacotherapy|2019|72
IGF2BP2-induced circRUNX1 facilitates the growth and metastasis of esophageal squamous cell carcinoma through miR-449b-5p/FOXP3 axis
|Journal of Experimental & Clinical Cancer Research|2022|64